The global healthcare landscape is witnessing a significant shift toward specialized ophthalmic care, with the Persistent Corneal Epithelial Defects (PCED) treatment market emerging as a critical niche. PCED occurs when the corneal surface fails to heal within the standard 10–14 day timeframe despite conventional therapy, often leading to vision loss if left untreated. As we look tow... Persistent Corneal Epithelial Defects Treatment Market Regulatory Review